ReachMD

Be part of the knowledge.™

Clinical Pharmacology

781

LikeLikedUnlike

Episodes 1-15 of 242

- Monica L. Baskin, PhD
  Peer
- Josep M. Llovet, MD, PhD
  Peer
0
CME/CE
Advocating for Action in HCC: Delivering Impartial and Personalized Care
Advocating for Action in HCC: Delivering Impartial and Personalized Care
1.00 credits
- Jennifer Caudle, DO
  Peer
- Archana Chatterjee, MD, PhD
  Peer
1
Medical Industry Feature
Pathways in Prevention: Addressing Seasonal Influenza in Older Adults
Pathways in Prevention: Addressing Seasonal Influenza in Older Adults
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Philip Ginsburg, MD
  Peer
0
GI Insights
Navigating Treatment Choices for Crohn’s Disease & Ulcerative Colitis
Navigating Treatment Choices for Crohn’s Disease & Ulcerative Colitis
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Philip Ginsburg, MD
  Peer
0
GI Insights
Reviewing the Role of Tofacitinib in Ulcerative Colitis
Reviewing the Role of Tofacitinib in Ulcerative Colitis
- Neilanjan Nandi, MD
  Peer
- Brian E. Lacy, MD, PhD
  Peer
0
GI Insights
The Pharmacological Perspective: Treatment Options & the 2020 IBS Guidelines
The Pharmacological Perspective: Treatment Options & the 2020 IBS Guidelines
- Mimi Secor, DNP, FNP-BC, FAANP
  Peer
- Karen Bloch, MD, MPH, FIDSA, FACP
  Peer
- Jarrod W. Kile, RPh, BCPS
  Peer
6
CME/CE Broadcast Replay
Connecting Care: A Multidisciplinary Panel Discussion on the Use of Neutralizing Monoclonal Antibodies in Ambulatory Patients With COVID-19
Connecting Care: A Multidisciplinary Panel Discussion on the Use of Neutralizing Monoclonal Antibodies in Ambulatory Patients With COVID-19
1.00 credits
- Jennifer W. Carlisle, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
7
CME/CE
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
0.50 credits
- Jennifer Caudle, DO
  Peer
- Andrew D. Badley, MD, FRCP(C), FACP, FIDSA
  Peer
- Chad Worz, PharmD, BCGP, FASCP
  Peer
1
CME/CE Broadcast Replay
Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies
Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies
0.75 credits
- Yohann Loriot, MD, PhD
  Peer
- Robert J. Motzer, MD
  Peer
6
CME/CE
Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies
Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies
1.00 credits
- Linda Bernstein, Pharm.D.
  Peer
6
The Drug Report
Another COVID-19 Vaccine Milestone Reached
Another COVID-19 Vaccine Milestone Reached
- Linda Bernstein, Pharm.D.
  Peer
4
The Drug Report
Second Ebola Virus Treatment Approved
Second Ebola Virus Treatment Approved
- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
7
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
- Linda Bernstein, Pharm.D.
  Peer
5
The Drug Report
Lawsuit Against HHS Highlights 340B Drug Pricing Dispute
Lawsuit Against HHS Highlights 340B Drug Pricing Dispute
- Linda Bernstein, Pharm.D.
  Peer
6
The Drug Report
FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine
FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine
- Ajay K. Gopal, MD
  Peer
0
$Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma$ $Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma$
CME/CE
Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma
Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma
0.25 credits

Programs 4/14/21

Segment Chapters

Playlist:

Recommended